 Livemint | India nixes Pfizer's patent on cancer-fighter Sutent FiercePharma India has blown another raspberry at Big Pharma. In its third strike against foreign drugmakers, the Indian patent office yanked Pfizer's ($PFE) patent on the kidney cancer drug Sutent. The move was a victory for local drugmakers Cipla and Natco Pharma ... India revokes patent for Pfizer's Sutent Cipla wins post-grant opposition against Pfizer's cancer drug |
